Application of Dermal Equivalent Accelerates the Healing of Thermal Injuries (Experimental Study)

Authors

  • Dimitri A. Zubov Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kiev Biotechnological Laboratory ilaya regeneration, Medical Company ilaya, Kiev
  • Roman G. Vasyliev Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kiev Biotechnological Laboratory ilaya regeneration, Medical Company ilaya, Kiev
  • Angela Ye. Rodnichenko Institute of Genetic and Regenerative Medicine of the National Academy of Medical Sciences of Ukraine, Kiev Biotechnological Laboratory ilaya regeneration, Medical Company ilaya, Kiev
  • Pavel P. Klymenko D.F. Chebotaryov Institute of Gerontology of the National Academy of Medical Sciences of Ukraine, Kiev
  • Lyudmyla I. Ostapchenko Institute of Biology of the Taras Shevchenko Kyiv National University, Kiev

Keywords:

dermal equivalent, multipotent mesenchymal stromal cells, collagen, fibrin, skin thermal injuries

Abstract

N/A Probl Cryobiol Cryomed 2013; 23(3):287–291.

References

Grin V.K., Popandopulo A.G., Fіstal E.Ya. et al. Experience of dermal equivalent application in combined treatment of severe burns. Transplantologіya 2004; 7 (3): 270–272.

Popandopulo A.G., Slipchenko I.O., Kazakov G.V. et al. Application of modified dermal equivalent in the treatment of diabetic foot ulcers. Bulletin of Urgent and Recovery Medicine 2003; 4 (3): 489–492 .

Sarkisov D.S., Gluschenko E.V., Tumanov V.P. et al. Experience in application of culture of fibroblasts in the treatment of patients with burns. Voenno-Med Zhurnal 1991; (10): 62–63.

Sarkisov D.S., Fedorov V.D., Gluschenko E.V. et al. Theoretical and practical aspects of the use of cultured fibroblasts in the restoration of the skin. Vestnik Ros Academii Nauk 1994; (6): 6–11.

Krasnodembskaya A., Song Y., Fang X. et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229–2238.

Le Blanc K., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nature Reviews 2012; 12: 383–396.

Mei S.H., Haitsma J.J., Dos Santos C.C. et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047–1057.

Patel A.N., Genovese J. Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy. Stem Cells and Cloning Advances and Applications 2011;4: 61–72.

Prockop D.J., Phinney D.G., Bunnell B.A. Mesenchymal stem cells: methods and protocols. Totowa, NJ: Humana Press, 2008.

Ryan J.M., Barry F.P., Murphy J.M. et al. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm 2005; 2 (8): 1–11.

Waterman R.S., Tomchuck S.L. Henkle, S.L. et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS Onee 2010; 5 (4): e10088.

Downloads

Published

2013-09-30

How to Cite

Zubov, D. A., Vasyliev, R. G., Rodnichenko, A. Y., Klymenko, P. P., & Ostapchenko, L. I. (2013). Application of Dermal Equivalent Accelerates the Healing of Thermal Injuries (Experimental Study). Problems of Cryobiology and Cryomedicine, 23(3), 287–291. Retrieved from http://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/308